vs

Side-by-side financial comparison of CURIS INC (CRIS) and Professional Diversity Network, Inc. (IPDN). Click either name above to swap in a different company.

Professional Diversity Network, Inc. is the larger business by last-quarter revenue ($1.7M vs $1.1M, roughly 1.5× CURIS INC). On growth, Professional Diversity Network, Inc. posted the faster year-over-year revenue change (3.1% vs -66.0%). Over the past eight quarters, Professional Diversity Network, Inc.'s revenue compounded faster (-1.7% CAGR vs -26.1%).

Curis Inc. is a U.S.-headquartered biotechnology company focused on the research, development and commercialization of innovative targeted oncology therapies and immuno-oncology treatments. It develops small molecule drug candidates addressing unmet medical needs in cancer care, and partners with leading pharmaceutical firms to deliver solutions to global patient populations.

Professional Diversity Network, Inc. is a U.S.-based firm offering end-to-end diversity, equity and inclusion (DEI) solutions for corporate clients. Its services include targeted recruitment support for underrepresented talent groups, customized DEI training programs, and diversity performance data analytics, serving clients across tech, healthcare, finance and other core commercial sectors nationwide.

CRIS vs IPDN — Head-to-Head

Bigger by revenue
IPDN
IPDN
1.5× larger
IPDN
$1.7M
$1.1M
CRIS
Growing faster (revenue YoY)
IPDN
IPDN
+69.0% gap
IPDN
3.1%
-66.0%
CRIS
Faster 2-yr revenue CAGR
IPDN
IPDN
Annualised
IPDN
-1.7%
-26.1%
CRIS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CRIS
CRIS
IPDN
IPDN
Revenue
$1.1M
$1.7M
Net Profit
$-2.9M
Gross Margin
33.7%
Operating Margin
-173.2%
Net Margin
-173.5%
Revenue YoY
-66.0%
3.1%
Net Profit YoY
-280.0%
EPS (diluted)
$1.84

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRIS
CRIS
IPDN
IPDN
Q4 25
$1.1M
$1.7M
Q3 25
$3.2M
$1.7M
Q2 25
$2.7M
$1.6M
Q1 25
$2.4M
$1.5M
Q4 24
$3.3M
$1.6M
Q3 24
$2.9M
$1.7M
Q2 24
$2.5M
$1.7M
Q1 24
$2.1M
$1.7M
Net Profit
CRIS
CRIS
IPDN
IPDN
Q4 25
$-2.9M
Q3 25
$-7.7M
$-2.4M
Q2 25
$-8.6M
$-476.0K
Q1 25
$-10.6M
$-722.1K
Q4 24
$-761.9K
Q3 24
$-10.1M
$-405.0K
Q2 24
$-11.8M
$-553.1K
Q1 24
$-11.9M
$-791.8K
Gross Margin
CRIS
CRIS
IPDN
IPDN
Q4 25
33.7%
Q3 25
44.0%
Q2 25
43.4%
Q1 25
52.2%
Q4 24
58.6%
Q3 24
58.9%
Q2 24
62.9%
Q1 24
62.2%
Operating Margin
CRIS
CRIS
IPDN
IPDN
Q4 25
-173.2%
Q3 25
-218.0%
-136.3%
Q2 25
-300.1%
-30.2%
Q1 25
-426.8%
-46.9%
Q4 24
-268.9%
-36.8%
Q3 24
-360.5%
-25.0%
Q2 24
-491.4%
-34.4%
Q1 24
-597.7%
-46.5%
Net Margin
CRIS
CRIS
IPDN
IPDN
Q4 25
-173.5%
Q3 25
-243.4%
-136.2%
Q2 25
-312.6%
-29.0%
Q1 25
-446.1%
-48.0%
Q4 24
-47.1%
Q3 24
-344.3%
-23.9%
Q2 24
-463.6%
-32.7%
Q1 24
-569.3%
-45.9%
EPS (diluted)
CRIS
CRIS
IPDN
IPDN
Q4 25
$1.84
Q3 25
$-0.49
Q2 25
$-0.68
Q1 25
$-1.25
Q4 24
$-1.10
Q3 24
$-1.70
Q2 24
$-2.03
Q1 24
$-2.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRIS
CRIS
IPDN
IPDN
Cash + ST InvestmentsLiquidity on hand
$5.1M
$217.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$5.5M
$11.7M
Total Assets
$20.0M
$17.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRIS
CRIS
IPDN
IPDN
Q4 25
$5.1M
$217.0K
Q3 25
$9.1M
$265.3K
Q2 25
$10.1M
$125.1K
Q1 25
$20.3M
$496.4K
Q4 24
$20.0M
$1.7M
Q3 24
$20.9M
$133.7K
Q2 24
$28.4M
$619.3K
Q1 24
$40.7M
$97.1K
Stockholders' Equity
CRIS
CRIS
IPDN
IPDN
Q4 25
$5.5M
$11.7M
Q3 25
$-14.7M
$8.9M
Q2 25
$-14.0M
$4.5M
Q1 25
$-6.6M
$4.9M
Q4 24
$-6.0M
$5.3M
Q3 24
$-8.7M
$2.1M
Q2 24
$-694.0K
$2.5M
Q1 24
$9.5M
$2.3M
Total Assets
CRIS
CRIS
IPDN
IPDN
Q4 25
$20.0M
$17.9M
Q3 25
$27.6M
$12.1M
Q2 25
$29.2M
$7.3M
Q1 25
$39.3M
$7.7M
Q4 24
$41.3M
$8.0M
Q3 24
$42.5M
$5.3M
Q2 24
$50.4M
$5.8M
Q1 24
$62.0M
$5.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRIS
CRIS
IPDN
IPDN
Operating Cash FlowLast quarter
$-6.4M
$1.4M
Free Cash FlowOCF − Capex
$1.4M
FCF MarginFCF / Revenue
84.4%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRIS
CRIS
IPDN
IPDN
Q4 25
$-6.4M
$1.4M
Q3 25
$-5.6M
$-2.7M
Q2 25
$-8.0M
$-495.5K
Q1 25
$-7.3M
$-284.1K
Q4 24
$-9.3M
$-1.2M
Q3 24
$-5.9M
$-556.9K
Q2 24
$-11.1M
$-224.4K
Q1 24
$-13.2M
$-543.1K
Free Cash Flow
CRIS
CRIS
IPDN
IPDN
Q4 25
$1.4M
Q3 25
$-2.7M
Q2 25
$-499.5K
Q1 25
Q4 24
$-1.2M
Q3 24
$-558.9K
Q2 24
$-225.9K
Q1 24
$-543.6K
FCF Margin
CRIS
CRIS
IPDN
IPDN
Q4 25
84.4%
Q3 25
-156.8%
Q2 25
-30.4%
Q1 25
Q4 24
-74.0%
Q3 24
-33.0%
Q2 24
-13.4%
Q1 24
-31.5%
Capex Intensity
CRIS
CRIS
IPDN
IPDN
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.2%
Q1 25
0.0%
Q4 24
1.3%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons